Close
Restaurants Canada Expresses Concern as BC Restaurants Brace for Chicken Price Surge May 23, 2024 06:38PM

Toronto, May 23, 2024 (GLOBE NEWSWIRE) -- Restaurants Canada is deeply concerned about the increase in the price of live BC chicken, approved by the BC Farm Industry Review Board. This decision will have significant consequences for British Columbia restaurants and consumers who value chicken as an affordable food choice. British Columbians already pay the highest retail price for chicken in the country, 40% higher than the Canadian average. While there are several... (continue reading...)


AXTI Stockholders: Robbins LLP Reminds AXTI Stockholders of Securities Fraud Class Action Against AXT, Inc. May 23, 2024 06:37PM

SAN DIEGO, May 23, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired AXT, Inc. (NASDAQ: AXTI) securities between March 24, 2021 and April 3, 2024. AXT, Inc. describes itself as a “worldwide materials science company that develops and produces high-performance compound and single element semiconductor substrates, also known as wafers."

For... (continue reading...)


Mediacom Communications Ready to Connect Customers in First Phase of 221-Mile Seminole County Fiber Network Buildout May 23, 2024 06:27PM

DONALSONVILLE, Ga., May 23, 2024 (GLOBE NEWSWIRE) -- Mediacom Communications announced completion of the first phase of construction to bring ultra-high-speed broadband to underserved areas of Seminole County. The activation of phase one means that over 100 of the 2,338 homes and businesses included in this project can now sign up for services.

Mediacom was awarded a $7.8 million grant through the Georgia Capital Project Fund Program for the Seminole County... (continue reading...)


Western Pacific Trust Company Announces Q1-2024 Results May 23, 2024 06:04PM

VANCOUVER, British Columbia, May 23, 2024 (GLOBE NEWSWIRE) -- WESTERN PACIFIC TRUST COMPANY (TSXV: WP) announces its financial results for the first quarter ending March 31, 2024. The Company reported significant growth across key performance metrics, underscoring its strong market position and operational effectiveness.

Key Financial Highlights for Q1-2024:

  • Revenue: $646,407, representing a 9.36% increase compared to Q1-2023
  • Net Income: $206,565 up by 11.92%... (continue reading...)

The Dominican Republic and Purdue University Sign MOU to Drive Semiconductor Growth May 23, 2024 06:01PM

SANTO DOMINGO, Dominican Republic, May 23, 2024 (GLOBE NEWSWIRE) -- The Ministry of Industry, Commerce, and MSMEs of the Dominican Republic (MICM) announced a significant Memorandum of Understanding (MOU) with Purdue University to propel the country's semiconductor industry and national development.

A Media Snippet accompanying this announcement is available by clicking on this link.

Strengthening Human Capital for a Technological Future

This collaboration... (continue reading...)


More Globe Newswire

View Older Stories

May 23, 2024 06:00PM Myriad Genetics Showcases New Research and Product Innovations Advancing Cancer Care at 2024 ASCO® Annual Meeting
May 23, 2024 06:00PM Associa Recognized as a US Best Managed Company
May 23, 2024 06:00PM Huize Holding Limited Reports First Quarter 2024 Unaudited Financial Results
May 23, 2024 05:55PM Gildan Board of Directors Resigns
May 23, 2024 05:52PM Acceleware Ltd. Reports First Quarter 2024 Financial and Operating Results
May 23, 2024 05:51PM Coherus Presents Preliminary Results from Phase I Dose Escalation Study of its Anti-chemokine receptor 8 (CCR8) Antibody, CHS-114, at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeti
May 23, 2024 05:49PM Parks! America, Inc. Announces Glass Lewis Recommends Parks! America Shareholders Vote “FOR” Each of the Director Nominees Recommended by the Board
May 23, 2024 05:49PM CORRECTION – The Herzfeld Caribbean Basin Fund, Inc. Announces Distribution in Stock and Cash
May 23, 2024 05:41PM Mountain America Credit Union Named Utah's Leading SBA Lender for Third Consecutive Year
May 23, 2024 05:40PM Stockholder Alert: Robbins LLP Informs Investors that a Class Action has been filed Against Cambium Networks Corporation (CMBM)
May 23, 2024 05:33PM 3Daughters to Participate in Women’s Health Panel During the 2024 BIO International Convention in San Diego, CA, June 3-6
May 23, 2024 05:30PM Elicio Therapeutics Announces Preliminary Data from the Ongoing AMPLIFY-7P Phase 1a Study of ELI-002 7P in Patients with mKRAS-driven Solid Tumors at the 2024 ASCO Annual Meeting
May 23, 2024 05:30PM Premier Health Reports 2024 Second Quarter Results
May 23, 2024 05:30PM Titanium Transportation Group Declares Quarterly Dividend
May 23, 2024 05:29PM ALT Stockholders: Robbins LLP Reminds ALT Stockholders of Securities Fraud Class Action Against Altimmune, Inc.
May 23, 2024 05:25PM MTTR Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Matterport to CoStar Group
May 23, 2024 05:25PM MTTR Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Matterport to CoStar Group
May 23, 2024 05:22PM HRBR Stockholders: Robbins LLP Reminds HRBR Stockholders of Securities Fraud Class Action Against Harbor Diversified, Inc.
May 23, 2024 05:23PM DOCS INVESTOR NEWS: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DOCS
May 23, 2024 05:22PM Trailblazing Dragons' Den Star Named United Nations Association in Canada's 2024 Global Citizen Laureate
May 23, 2024 05:21PM INTC Stockholders: Robbins LLP Reminds INTC Stockholders of Securities Fraud Class Action Against Intel Corporation
May 23, 2024 05:18PM Fresh2 Group Ltd. Announces Receipt of a Delinquency Compliance Alert Notice from Nasdaq
May 23, 2024 05:18PM Fresh2 Group Ltd. Announces Receipt of a Delinquency Compliance Alert Notice from Nasdaq
May 23, 2024 05:15PM Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
May 23, 2024 05:13PM SpringWorks Therapeutics Announces Data to be Presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
May 23, 2024 05:11PM Special Olympics Florida and Orlando Health Announce Five-Year Partnership
May 23, 2024 05:10PM Sensei Biotherapeutics Presents Promising Clinical Data from Phase 1 Dose Escalation Study of SNS-101
May 23, 2024 05:09PM Ivy Brain Tumor Center announces Phase 0/2 clinical readout of niraparib indicating significant improvement in overall survival of newly diagnosed glioblastoma patients
May 23, 2024 05:06PM G1 Therapeutics Announces Upcoming Presentation at the 2024 American Society of Clinical Oncology (ASCO) Meeting
May 23, 2024 05:05PM Updated Phase 1 Clinical Data for SYS-6002 (CRB-701) to be presented at 2024 ASCO Annual Meeting
May 23, 2024 05:05PM FibroGen Announces Presentation of Positive Interim Data from the Phase 1b Study of FG-3246 (FOR46) in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer (m
May 23, 2024 05:05PM NKGen Biotech Publishes Phase 1 Interim Analysis Results of SNK02 Allogeneic NK Cell Therapy in Advanced Solid Tumors at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
May 23, 2024 05:05PM Cogent Biosciences Appoints Cole Pinnow as Chief Commercial Officer
May 23, 2024 05:05PM BioAtla Presenting Phase 1 Evalstotug Clinical Trial Data Demonstrating Clinical Benefit at the Upcoming 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
May 23, 2024 05:05PM Compass Therapeutics to Present Phase 1 Data for CTX-471, A Novel CD137 Agonist Antibody, Demonstrating Anti-Tumor Activity in Patients Who Have Progressed on Approved PD-1 or PD-L1 Inhibitors at the
May 23, 2024 05:05PM I-Mab Announces Encouraging Phase 1 Clinical Data of PD-L1x4-1BB Bispecific Antibody Ragistomig at ASCO 2024
May 23, 2024 05:05PM Elcora Announces Share Consolidation
May 23, 2024 05:05PM Affimed Announces Positive Early Efficacy and Progression Free Survival Results of AFM24-102 Study in EGFR Wild-Type Non-Small Cell Lung Cancer at the Annual Meeting of the American Society of Clinica
May 23, 2024 05:04PM Cullinan Therapeutics to Present First Data for CLN-619, a Novel Anti-MICA/B Antibody, in Combination with a Checkpoint Inhibitor and Updated Monotherapy Data at ASCO 2024
May 23, 2024 05:03PM Promising Anti-tumor Activity of Novel Costimulatory Bispecific Antibody REGN7075 (EGFRxCD28) in Combination with Libtayo® (cemiplimab) to be Reported at ASCO
May 23, 2024 05:01PM Zentalis Pharmaceuticals to Present Promising Results from Phase 1 Trial of Azenosertib and Gemcitabine in Relapsed or Refractory Osteosarcoma at 2024 American Society of Clinical Oncology Annual Meet
May 23, 2024 05:01PM Cogent Biosciences Announces Positive Updated Lead-In Data from Ongoing Phase 3 PEAK Trial Evaluating Bezuclastinib in Combination with Sunitinib in Patients with Gastrointestinal Stromal Tumors (GIST
May 23, 2024 05:01PM HOOKIPA Pharma Announces Positive Clinical Data to be Presented at the American Society for Clinical Oncology 2024 Annual Meeting
May 23, 2024 05:00PM Timbercreek Financial Declares May 2024 Dividend
May 23, 2024 05:00PM Arvinas Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Congress
May 23, 2024 05:00PM Canadian Premium Sand Inc. Announces Second Quarter 2024 Results
May 23, 2024 05:00PM Werewolf Therapeutics to Present Updated Data from Phase 1/1b Clinical Trial of WTX-124 as Monotherapy and in Combination with Pembrolizumab in Solid Tumors at 2024 ASCO Annual Meeting
May 23, 2024 05:00PM Bio-Path Holdings to Present Data at American Society of Clinical Oncology (ASCO) Annual Meeting
May 23, 2024 05:00PM Replimune to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
May 23, 2024 05:00PM Theratechnologies’ Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid Tumors
View Older Stories